eConsent provides several means of delivering complex trial information to the trial participant that improves comprehension and engagement. The use of eConsent has increased due to various benefits. The current COVID-19 pandemic has further accelerated this trend.

eConsent eliminates the need for physical contact in the consent process, overcoming challenges like COVID-19 measures, site closures, quarantines, and travel restrictions.

In our latest white paper about eConsent we touch upon some of the considerations when implementing eConsent in your clinical trial.

Subscribe to our newsletter or read our whitepapers.

    You must agree before submitting.

    For more information on how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

    Input this code: captcha